Hondius Andes: Clinical Protocols Emphasize Supportive Care for HPS/HCPS
As the MV Hondius Andes outbreak continues, medical experts underscore the critical role of advanced supportive care, including mechanical ventilation and ECMO, in managing severe Hantavirus Pulmonary Syndrome (HPS/HCPS) cases onboard and ashore.
Supportive Care Remains Cornerstone of HPS/HCPS Treatment
PRAIA, Cape Verde – Medical professionals managing the Hantavirus Pulmonary Syndrome (HPS), also known as Hantavirus Cardiopulmonary Syndrome (HCPS), cases associated with the MV Hondius Andes outbreak are primarily focused on aggressive supportive care, according to statements from health authorities. With no specific antiviral treatment approved for HPS/HCPS, clinical strategies revolve around managing the severe respiratory and cardiac complications that characterize the disease.
Understanding the Clinical Challenge
HPS/HCPS is a severe, often fatal, respiratory illness caused by hantaviruses. Infection typically occurs through inhalation of aerosolized droppings, urine, or saliva of infected rodents. The MV Hondius Andes incident, anchored off Praia since May 2026, has prompted bigly international medical attention due to the complexities of managing such an outbreak in a maritime context and subsequent ashore care. The incubation period for HPS/HCPS can range from one to eight weeks, although it typically manifests within two to four weeks post-exposure. Initial symptoms often resemble common viral illnesses, including fever, muscle aches, headache, and gastrointestinal complaints. But, the disease can rapidly progress to the critical cardiopulmonary phase.
Progression to Cardiopulmonary Phase
In the critical phase, patients develop acute respiratory distress syndrome (ARDS) and cardiogenic shock. This is driven by increased capillary permeability in the lungs, leading to pulmonary edema, and direct myocardial depression, resulting in impaired heart function. The hallmark of severe HPS/HCPS is the rapid accumulation of fluid in the lungs, making breathing extremely difficult, coupled with a dramatic drop in blood pressure. As of 2026-09-14, health organizations involved in the response, including the World Health Organization (WHO) and regional health bodies, reiterate that early recognition and prompt initiation of advanced supportive care are paramount for improving patient outcomes.
Treatment Protocols: Mechanical Ventilation and Hemodynamic Support
The primary goals of HPS/HCPS management are to maintain adequate oxygenation, support cardiovascular function, and manage fluid balance. Patients in the critical cardiopulmonary phase often require intensive care unit (ICU) admission. * Oxygen Therapy: Supplemental oxygen is administered to maintain arterial oxygen saturation. For patients with worsening respiratory distress, non-invasive ventilation (NIV) may be attempted, though several will progress to requiring mechanical ventilation. * Mechanical Ventilation: Invasive mechanical ventilation is a critical intervention for patients developing ARDS. Strategies focus on lung-protective ventilation, using low tidal volumes and appropriate positive end-expiratory pressure (PEEP) to minimize ventilator-induced lung injury. * Fluid Management: This is a delicate balance. While patients can be severely hypotensive (low blood pressure) due to systemic capillary leak, aggressive intravenous fluid administration can exacerbate pulmonary edema. So, cautious use of vasopressors (e.g., norepinephrine, dopamine) is often preferred to maintain blood pressure and organ perfusion. * Cardiac Support: Inotropes may be used to improve myocardial contractility in cases of severe cardiogenic shock.
Extracorporeal Membrane Oxygenation (ECMO) Availability
For the most critically ill patients who fail conventional mechanical ventilation and maximum medical therapy, Extracorporeal Membrane Oxygenation (ECMO) serves as a life-sustaining measure. ECMO provides temporary cardiac and respiratory support by oxygenating the blood outside the body. It allows the lungs and heart to rest and recover from severe injury. The availability of ECMO for patients from the MV Hondius Andes has been a crucial aspect of the advanced medical response. Several medical facilities in the region and abroad, equipped with specialized ECMO teams, have been identified as potential referral centers for severe cases. The logistical challenges of transporting critically ill patients requiring ECMO from the vessel or initial onshore facilities to tertiary care centers are bigly and have required careful coordination among international medical teams, as stated by officials involved in the medical evacuation efforts.
Drivers of Mortality
Mortality in HPS/HCPS is primarily driven by progressive respiratory failure leading to refractory hypoxemia (low blood oxygen levels despite treatment) and severe cardiogenic shock. The rapid progression of the disease and the high inflammatory response contribute to multiorgan dysfunction syndrome (MODS) in some fatal cases. Factors associated with increased mortality include delayed diagnosis, lack of access to advanced critical care interventions like mechanical ventilation and ECMO, and the severity of initial presentation. Early identification of individuals exposed to hantavirus, vigilant monitoring for symptom onset. Swift transfer to facilities capable of providing advanced critical care are critical to mitigating the high mortality rates historically associated with severe HPS/HCPS cases. The ongoing response to the MV Hondius Andes situation continues to underscore these challenges and the importance of strong clinical preparedness.
